AbbVie (ABBV) Short-term Investments (2012 - 2025)

AbbVie (ABBV) has 14 years of Short-term Investments data on file, last reported at $28.0 million in Q4 2025.

• Quarterly Short-term Investments fell 9.68% year-over-year to $28.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.0 million (down 9.68% YoY) and the FY2025 annual result came in at $28.0 million, down 9.68% from the prior year.
• Short-term Investments eased to $28.0 million in Q4 2025 per ABBV's latest filing, from $42.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.5 billion in Q1 2022 and bottomed at $1.0 million in Q1 2025.
• The 5-year median for Short-term Investments is $28.0 million (2022), against an average of $178.8 million.
• The widest annual swing landed in 2022, when Short-term Investments jumped 6600.0%; it then slumped 99.51% in 2023.
• Tracing ABBV's Short-term Investments over 5 years: stood at $84.0 million in 2021, then tumbled by 66.67% to $28.0 million in 2022, then slumped by 92.86% to $2.0 million in 2023, then soared by 1450.0% to $31.0 million in 2024, then dropped by 9.68% to $28.0 million in 2025.
• Per Business Quant, the three latest ABBV Short-term Investments figures stand at $28.0 million (Q4 2025), $42.0 million (Q3 2025), and $1.0 million (Q1 2025).

Peer Comparison